A taurine compound preparation with functions of lowering blood fat and blood sugar
A compound preparation and hypoglycemic technology, which can be used in medical preparations containing active ingredients, antitoxins, drug combinations, etc., can solve the problems of inducing other diseases, side effects, poor targeting, etc., to reduce blood lipids, improve immunity, and improve the effect significant effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0025] Example 1 Capsule dosage form preparation (capsule specification: 0.6g)
[0026] Compound preparation 1 (80% taurine, 7% arginine, 7% gypenosides, 6% vitamin E);
[0027] Composite preparation 2 (83% taurine, 6% arginine, 6% gypenosides, 5% vitamin E);
[0028] Compound preparation 3 (86% of taurine, 5% of arginine, 5% of gypenosides, 4% of vitamin E);
[0029] Weigh the raw materials in proportion, mix them, and pack them into capsules, 0.6g of each medicine powder.
Embodiment 2
[0030] Embodiment 2 tablet preparation (tablet specification: 0.6g)
[0031] Compound preparation 1 (80% taurine, 7% arginine, 7% gypenosides, 6% vitamin E);
[0032] Composite preparation 2 (83% taurine, 6% arginine, 6% gypenosides, 5% vitamin E);
[0033] Compound preparation 3 (86% of taurine, 5% of arginine, 5% of gypenosides, 4% of vitamin E);
[0034] The raw materials are weighed in proportion, supplemented with commonly used excipients for tablets to prepare tablets, each 0.6g, wherein the active pharmaceutical ingredients are not less than 80%.
experiment example 1
[0036] In order to verify the effect of the taurine compound preparation for lowering blood fat and blood sugar provided by the present invention, the inventors conducted animal experiments on the medicaments prepared in the above-mentioned Examples 1 and 2. The test methods and results are as follows.
[0037] 1. Animal experiment of auxiliary blood lipid lowering function
[0038] 1.1 Materials and methods
[0039] 1.1.1 Test samples
[0040] Adopt the compound preparation of the embodiment of the present invention 1 as test sample, but without capsule, direct medicine powder test.
[0041] 1.1.2 Experimental animals and feeding conditions
[0042] SPF-grade healthy male Wistar rats were selected, provided by Beijing Weitong Lihua Experimental Animal Technology Co., Ltd., the test conditions were SPF-grade animal breeding laboratory, and the feeding method was raised in three-dimensional cages, with 5-7 rats per cage, barrier system, indoor The temperature was 18±2°C, the...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com